Dr. Thomas Frischmuth

B12: Baseclick GmbH, Germany

Expertise

​Dr. Thomas Frischmuth holds a PhD in biology. In his career he worked for 15 years as scientist (Associate Professor) in the molecular biology and biotechnology fields where he has supervised 28 students and was responsible for 10 granted projects (DFG, EU and private). For the last 14 years he was acting director for several life science venture funds and manager of small and medium size companies including baseclick GmbH where he is the chief executive officer (CEO). Besides, Dr. Thomas Frischmuth is reviewer for the BMWi, BMBF, German Israel Foundation, USDA Department and various journals.

http://www.baseclick.eu

Role in LightDyNAmics

Supervisor of ESR13

Selected Publications

  1. WO 2006/117161: New labelling strategies for the sensitive detection of analytes.
  2. J. Gierlich, G. A. Burley, P. M. E. Gramlich, D. M. Hammond, T. Carell. “Click Chemistry as a Reliable Method for the High-Density Postsynthetic Functionalization of Alkyne-Modified DNA. Org.” Lett. 2006, 8, 3639–3642.
  3. P. M. E. Gramlich, C. T. Wirges, A. Manetto, T. Carell. “Postsynthetic DNA Modification through the Copper-Catalyzed Azide- Cycloaddition Reaction.” Angew. Chem. Int. Ed. 2008, 47, 8350-8358.
  4. G. Barbarella et al. “Oligothiophene-5-Labeled Deoxyuridines for the Detection of Single Nucleotide Polymorphisms Bioconjugate.” Chem. 2008, 19, 171-177.
  5. M.L. Capobianco, G.Barbarella, A. Manetto. “Oligothiophenes as Fluorescent Markers for Biological Applications.” Molecules, 2012, 17, 910-933.

This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement No 765266.

© accelopment Schweiz AG 2024